Abstract
The increasing life expectancy of Indians is likely to result in an increase in age-related disorders like Alzheimer’s disease. Alzheimer’s disease is a chronic, progressive, untreatable neurodegenerative disorder characterized by apraxia, aphasia, agnosia and severe cognitive deficits. Several behavioural changes like anxiety, hallucinations, depression and delusions are also experienced. AD have a serious impact on families, caregivers, and the healthcare system in general. Although lot of theories and treatments have been proposed targeting pathophysiology of AD yet, current treatments are merely palliative and do little to slow the progression of the disease. Yet, a great deal of progress has been made in the understanding of AD and many promising therapies have entered clinical trials. Several of key areas have been recognized and out of them life style modifications and role of food stuff has been regarded as inseparable and crucial factor involved. Present review is an effort to investigate the status and role of different common food stuffs and supplements in pathogenesis of AD.
References
World Health Organization, “Dementia: A Public Health Priority,” April 11, 2012, p.2; http://www.who.int/mental_health/publications/demen tia_report_2012)
Salloway S, Correia S.(2009).Cleveland Clinic Journal of Medicine.76(1):49–58.
Casserly I,Topol E.(2004)Lancet.363: 1139–46
http://www.alz.co.uk/media/nr100921.html)for Alzheimer’sDisease International World Alzheimer Report 2010:Published by Alzheimer’s Disease International (ADI) 21 September 2010 ).
http://www.brightfocus.org/alzheimers/about/underst anding/facts.html
Alzheimer’s Association. (2012)Alzheimer’s disease facts and figures. Alzheimers Dement. 8, 131–168.
Burns A, Jacoby R, Levy R.(1990) Br J Psychiatry.157 (7):72-6.
Sharma V, Thakur V et al.(2012)Bulletin of Clinical Psychopharmacology.22(1).
Querfurth HW, LaFerla FM.(2010).N Engl J Med.364(6):588.
Solfrizzi, V, Capurso C et al.(2008)Expert Rev. Neurother.8: 133-158.
Solfrizzi, V.; Panza, F et al.(2008). J. Neural Transm.110:95-110.
Kivipelto, M.; Solomon, A. Alzheimer's disease - the ways of prevention. J. Nutr. Health Aging 2008, 12, 89- 94.
Heyman A, Wilkinson WE et al.,(1984) Ann. Neurol.15, 335-341.
Shie FS, JinLW et al(2002). Neuroreport13:455-459.
Smith MA, Rottkamp CAet al(2000).Biochim. Biophys. Acta 1502:139-144.
LuchsingerJA,Tang MX et al(2002).Arch. Neurol.59:1258-1563.
Hu FB,.Rimm E et al(1999)Am. J. Clin. Nutr.69:243-249. 18. Kant AK et al.(1991) J. Am. Diet. Assoc.91: 1532-1537.
Randall E,Marshall JR et al(1990)Am. J. Clin. Nutr. 52:
-745.
Dietschy JM, Turley SD.(2001).Curr Opin Lipidol:12:105–12.
Pfrieger FW.(2003).BiochimBiophys Acta.1610:271– 80.
Ledesma MD, Dotti CG(2006). FEBS Lett. 580: 5525- 5532.
Robert L, Raffaï,Karl H. (2003).J. Lipid Res.44: 1423– 1430.
Poirier J, Baccichet A et al.(1993). Neuroscience 55: 81-90 (1993).
Pfrieger FW. (2003).Cell Mol Life Sci. 60: 11558- 11571.
Jurevics H, Morell P(1995). J Neurochem 64: 895-901.
Sparks DL(1994). Exp Neurol. 126: 88-94.
Notkola IL, Sulkava R et al. (1998). Neuroepidemiology.17: 14–20.
Frears ER, Stephens DJ et al. (1999). Neuroreport. 10:1699–705.
Simons M, Keller P et al.(1998).Proc Natl Acad Sci USA.95:6460–64.
Hardy J, Selkoe DJ.(2002). Science.297:353–6.
Winterbourn CC(1995).Toxicol Lett 82–83:969–974.
Grundman M(2000). Am J Clin Nutr.72: 630-636.
Henderson AS(1988).Acta Psychiatr. Stand. 78: 257- 275.
Nakatani, N(2000). Biofactors.13:141–146.
Priyadarsini KI, Guha SN(1998).Free Radic Biol Med.24:933–941
Martin-Aragon S, Benedi JM(1997). J Pharm Pharmacol.49:49–52.
Sreejayan A, Rao MN(1997).J Pharm Pharmacol.49:105–107.
Halliwell B, Gutteridge JMC(1989). Radicals in Biology and Medicine, 2nd ed. Clarendon Press, Oxford.
JennerP, Olnaw CW (1996).Neurology 47 (Suppl.)
:161–176.
Simonian NA, Coyle JT(1996).Annual Review of Pharmacological Toxicology 36:83–106.
Jenner P, OlnawCW. (1996). Neurology 47 (Suppl.)
:161–176.
Gorman AM, McGowan Aet al(1996).Journal of Neurological Science. 139: 45–52.
Solfrizzi V, Capurso C et al.(2008).Expert Rev. Neurother.8: 133-158.
Frears ER, Stephens DJ et al (1999). Neuroreport.10:1699–705.
Butterfield DA, Stadtman ER(1997).Adv Cell Aging Gerontol. 2:161–191.
Butterfield DA,Howard BJ(1997). Proc Natl Acad Sci USA 94: 674–678.
Calabrese V, Scapagnini G et al.,(2001).Neu- rochem Res.26:739–764.
Gonzalez-Gross M,Marcos A et al.,(2001).Br J Nutr.86:313–321.
Youdim K, Joseph JA,(2001). Free Radic Biol Med. 30:583–594.
Birks J & Harvey R. (2006). Donepezil for dementia due to Alzheimer’s disease. Cochrane Database Syst Rev (1) CD001190.
Birks J, Grimley EJ, Iakovidou V et al. (2000). (4) CD001191. reosa SA, Sheriff F, Mc Shane R. (2005). Cochrane Database Syst Rev (2) CD003154.
Green C, Picot J, Loveman E et al. (2005). Pharmacoeconomics, 23:1271-1282.
Alejandro Gella and Irene Bolea (2011). Dr. Suzanne De La Monte (Ed.), ISBN: 978-953-307-690-4.
Bendich A, Olson JA(1989).FASEB J.3:1927-1932.
Napoli JL(1999). Biochim Biophys Acta.1440:139-162.
Lee HP, Casadesus G, Zhu X et al.(2009).Expert Rev Neurother.9: 1615–1621.
Ono K, Yoshiike Y.(2004).Exp Neurol.189:380–392.
Sahin M, Karauzum SB, Perry G et al. (2005).Neurotox Res, 7:243-250.
Goodman AB. (2006). J Cell Physiol, 209:598-60.
Jae-Hyeok Heo, Hyon-Lee et al. (2013). AM J ALZHEIMERS DIS OTHER DEMEN 28(2):120-125.
Stocker R(1994).Curr OpinLipidol. 5:422–433.
Lan TH(2010).American Journal of Alzheimer’sDisease & Other Dementias. 00(0) 1-10.
Annweiler C, Allali G(2009).Eur J Neurol.16:1083- 1089.
Annweiler C, Schott AM et al. (2010). Neuropsychobiology.62:139-150.
Brewer LD, Thibault V et al. (2001).J Neurosci. 21:98- 108.
Cedric Annweiler, Bruno Fantino(2011).Trials 2011, 12:230.
Kolsch H, Ludwig M(2001). J Neural Transm.108:475– 488.
Kumar PT, Antony S(20110.J Nutr Biochem.22(5): 418– 425.
Ricciotti E, Fitzgerald GA(2011). Thromb Vasc Biol.31(5): 986–1000.
Wanatabe Y, Hamada K (1989). Brain Res. 478 (1):142–148.
Kaufmann WE, Worley PF(1996).Proc Natl AcadSci U S A. 93(6): 2317–2321.
Yasojima K, Schwab C (1999).Brain Res.830 (2):226– 236.
Ho L, Pieroni L(1999).J Neurosci Res.57(3): 295–303.
Moreno J, Krishnan AV et al (2005). Cancer Res.65 (17):7917–7925.
Apama R, Subhashini J et al(2008).J Cell Bio- chem.104(5): 1832–1842.
Meydani M. Vitamin E.(1995).Lancet.345:170–5.
Stocker R.(1994).Curr OpinLipidol. 5:422–433.
Neuzil J, Weber C, Kontush A (2001). Atherosclerosis.157:257–283.
Vatassery GT(1998).Geriatrics53(suppl1):S25–S27.
Michael Grundman(2007).Am J Clin Nutr. 71(suppl)
:630S–6S.
Behl C, Davis JB(1994).Cell 1994;77:817–27.
Goodman Y, Mattson MP(19994).Exp Neurol.128:1– 12.
Behl C, Davis J, Cole GM et al.(1992).Biochem Biophys Res Commun.186:944–50.
Murphy TH, Schnaar RL(1990).FASEB J.4:1624–33.
Clement M, Bourre JM(1997).Biochim Biophys Acta 1334:173–181.
Meydani SN, Meydani M et al.(1998).Am J Clin Nutr. 68:311–318.
Behl C, Davis J, Cole GM, Schubert D(1992).Biochem Biophys Res Commun.186:944 950.
Kolsch H, Ludwig M(2001). J Neural Transm.108:475– 488.
Leon D et al.(1983).American Journal of Neuroradiology.7:568-571.
Crafts, S., et al(2000).Annuals of the New York Academy of Science.903:222-228.
Ronald Devere(2009).Practical Neurology.7:14-16.
Crafts S et al.(2000).Annuals of the New York Academy of Science.903:222-228.
Reger MA et al.(2004).Neurobiology of Aging.25:311- 314.
Costantini LC et al.(2007).American Academy of Neurology Conference; April 28 to May 5 of 2007.
Costantini LC, Barr LJ, Vogel JL(2008).BMC Neurosci.9(Suppl 2):16-21.
Nicholson C(2008).Neuroscience.9:584–5.
Yudkoff M, Daikhin Y (2005).Neurochem Int.47:119– 28.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array